EUCRU
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
EUCRU
Delisted
EUCRU was delisted on the 26th of April, 2023.
19 hedge funds and large institutions have $18.4M invested in Eucrates Biomedical Acquisition Corp. Unit in 2022 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
19
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$986K | |
| 2 | +$781K | |
| 3 | +$780K | |
| 4 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$780K |
| 5 |
RCM
Rivernorth Capital Management
West Palm Beach,
Florida
|
+$747K |
Top Sellers
| 1 | -$7.29M | |
| 2 | -$4.99M | |
| 3 | -$436K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$100K |
| 5 |
CS
Clear Street
New York
|
-$90K |